HUE049298T2 - Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában - Google Patents

Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában

Info

Publication number
HUE049298T2
HUE049298T2 HUE15702266A HUE15702266A HUE049298T2 HU E049298 T2 HUE049298 T2 HU E049298T2 HU E15702266 A HUE15702266 A HU E15702266A HU E15702266 A HUE15702266 A HU E15702266A HU E049298 T2 HUE049298 T2 HU E049298T2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
immediate release
release tablets
stable pharmaceutical
Prior art date
Application number
HUE15702266A
Other languages
English (en)
Inventor
Hidalgo Sergio Arroyo
Roses Mireia Pladevall
Original Assignee
Galenicum Health Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50033373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE049298(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galenicum Health Sl filed Critical Galenicum Health Sl
Publication of HUE049298T2 publication Critical patent/HUE049298T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE15702266A 2014-02-03 2015-02-03 Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában HUE049298T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14153671 2014-02-03

Publications (1)

Publication Number Publication Date
HUE049298T2 true HUE049298T2 (hu) 2020-09-28

Family

ID=50033373

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15702266A HUE049298T2 (hu) 2014-02-03 2015-02-03 Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában

Country Status (9)

Country Link
EP (1) EP3102187B1 (hu)
CY (1) CY1123022T1 (hu)
ES (1) ES2792506T3 (hu)
HU (1) HUE049298T2 (hu)
PL (1) PL3102187T3 (hu)
PT (1) PT3102187T (hu)
RS (1) RS60393B1 (hu)
SI (1) SI3102187T1 (hu)
WO (1) WO2015114152A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3102187T (pt) 2014-02-03 2020-06-17 Galenicum Health Sl Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata
WO2021076066A1 (en) 2019-10-14 2021-04-22 Santa Farma İlaç Sanayi̇ A.Ş. Oral formulations comprising sitagliptin hci monohydrate with improved pharmaceutical characteristics
JP7423264B2 (ja) 2019-10-17 2024-01-29 日本ジェネリック株式会社 シタグリプチン含有錠剤
GR1010089B (el) 2020-09-15 2021-09-27 Φαρματεν Α.Β.Ε.Ε. Στερεη φαρμακοτεχνικη μορφη περιεχουσα σιταγλιπτινη και μεθοδος παρασκευης αυτης
WO2022074664A1 (en) * 2020-10-05 2022-04-14 V-Ensure Pharma Technologies Private Limited An immediate release composition of sitagliptin hydrochloride
CN113143929B (zh) * 2021-04-15 2023-04-07 浙江诺得药业有限公司 一种西格列汀复方制剂的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247709B1 (en) 1986-04-17 1991-01-02 Alza Corporation Chlorpheniramine therapy
JO2625B1 (en) 2003-06-24 2011-11-01 ميرك شارب اند دوم كوربوريشن Phosphoric acid salts of dipeptidyl betidase inhibitor 4
WO2005072530A1 (en) * 2004-01-16 2005-08-11 Merck & Co., Inc. Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
US8414921B2 (en) 2005-12-16 2013-04-09 Merck Sharp & Dohme Corp. Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
US8334385B2 (en) 2007-11-02 2012-12-18 Glenmark Generics Limited Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof
EP2650299A1 (en) 2008-07-03 2013-10-16 Ratiopharm GmbH Crystalline salts of sitagliptin
EP2470542A4 (en) 2009-08-28 2013-04-24 Reddys Lab Ltd Dr PREPARATION OF SITAGLIPTIN AND SALTS THEREOF
US20130158265A1 (en) * 2010-08-27 2013-06-20 Dhananjay Govind Sathe Sitagliptin, salts and polymorphs thereof
EP2691083B1 (en) 2011-03-29 2017-08-02 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition of sitagliptin
WO2012166420A1 (en) 2011-05-27 2012-12-06 Merck Sharp & Dohme Corp. Phosphoric acid salts of sitagliptin
ES2487271T3 (es) 2011-10-06 2014-08-20 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulaciones de dosificación sólidas inhibidoras de DPP-IV
ES2421956B1 (es) 2012-03-02 2014-09-29 Moehs Ibérica S.L. Nueva forma cristalina de sulfato de sitagliptina
PT3102187T (pt) 2014-02-03 2020-06-17 Galenicum Health Sl Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata

Also Published As

Publication number Publication date
EP3102187A1 (en) 2016-12-14
EP3102187B1 (en) 2020-03-25
WO2015114152A1 (en) 2015-08-06
ES2792506T3 (es) 2020-11-11
PL3102187T3 (pl) 2020-10-19
PT3102187T (pt) 2020-06-17
RS60393B1 (sr) 2020-07-31
SI3102187T1 (sl) 2020-08-31
CY1123022T1 (el) 2021-10-29

Similar Documents

Publication Publication Date Title
IL252477A0 (en) 2-aminopyrimidine compound, pharmaceutical structure and its use
HK1225655A1 (zh) 包含azd9291的藥用組合物
IL246655A0 (en) A medical preparation containing a pyridyl amino acetic acid compound
HUE052386T2 (hu) Hatóanyagok felszabadítására szolgáló szemcsék
SI3135275T1 (sl) Farmacevtski pripravek, ki je sposoben vključitve lenalidomida v različnih kristaliničnih modifikacijah
HK1245086A1 (zh) 處方藥物組成及其製備和使用
HUE049298T2 (hu) Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában
ZA201606075B (en) Pharmaceutical compositions of sitagliptin
RS59626B1 (sr) Farmaceutska kompozicija koja sadrži mirabegron
HK1245085A1 (zh) 處方藥物組成及其製備和使用
RS61611B1 (sr) Upotreba kompozicije koja sadrži benzoat kod poremećaja ciklusa uree i neurodegenerativnih poremećaja
IL266825A (en) Pharmaceutical formulation containing tadalafil
SI3236952T1 (sl) Farmacevtski sestavek v obliki tablet
PL3200772T3 (pl) Kompozycje farmaceutyczne zawierające alpelisyb
SG11201608123VA (en) Pharmaceutical composition for external use
HUE055943T2 (hu) Anagrelidet tartalmazó gyógyszerkészítmények
ZA201500995B (en) Low dose pharmaceutical composition
SG11201608124XA (en) Pharmaceutical composition for external use
SG11201608122PA (en) Pharmaceutical composition for external use